AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$1.83
+0.02 (+1.11%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+400.0% upside
Low Target
$5.34
Average Target
$9.15
High Target
$10.98
Current Price
$1.83
Current
$1.83
$1.83
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Scenario Analysis
Bear Case
$5.34
191.8%
Low target
Base Case
$9.15
+400.0%
Avg target
Bull Case
$10.98
+500.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$3.07
-40.3% from high
52-Week Low
$1.75
+4.6% from low
Target vs 52W High
$9.15
+198.5% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.26
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals